Brief: Acurx Pharmaceuticals Announces Presentation Of Results From Leiden University Medical Center Public-Private Partnership For Its DNA pol IIIC Inhibitors
09/06/2025 13:08
June 9 (Reuters) - Acurx Pharmaceuticals Inc ACXP.O: ACURX PHARMACEUTICALS ANNOUNCES PRESENTATION OF RESULTS FROM LEIDEN UNIVERSITY MEDICAL CENTER PUBLIC-PRIVATE PARTNERSHIP FOR ITS DNA POL IIIC INHIBITORS AT THE FEDERATION OF AMERICAN SOCIETIES FOR EXPERIMENTAL BIOLOGY SCIENTIFIC CONFERENCE Source text: ID:nPn4xwlCKa Further company coverage: ACXP.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Acurx Pharmaceuticals
See all newsAcurx Pharmaceuticals Q1 net loss narrows as expenses fall
Brief: Acurx Pharmaceuticals To Discuss First Quarter 2026 Financial Results On May 12, 2026 Conference Call And Provide Business Update
Brief: Acurx Pharmaceuticals, Inc. Announces Closing Of Up To $7.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Acurx Pharmaceuticals Q4 net loss narrows on lower R&D spend
Acurx Pharma Q3 net loss narrows to $2 mln